Market Research

Atherectomy Devices Market By Product (Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, Others), By End User (Hospitals, Ambulatory surgery centers, Others): Global Opportunity Analysis and Industry Forecast, 2

Best Price Guarantee Length Publisher Published Date SKU
from $3,930 290 Pages Allied Market Research March, 2023 ALMR18022746
Best Price Guarantee
Price from $3,930
Length 290 Pages
Publisher Allied Market Research
Published Date March, 2023
SKU ALMR18022746

Atherectomy Devices Market By Product (Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, Others), By End User (Hospitals, Ambulatory surgery centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031


The global atherectomy devices market was valued at $ 787.12 million in 2021 and is projected to reach $ 2111.97 million by 2031, registering a CAGR of 10.5% from 2022 to 2031.  

Atherectomy devices are medical devices used to remove plaque buildup in arteries, particularly in cases of atherosclerosis. Atherosclerosis is a disease of the arteries in which fatty deposits, known as plaques, build up on the inner walls of the arteries, leading to their narrowing and hardening. 

Atherectomy devices are medical devices used to remove atherosclerotic plaque from the walls of arteries. Atherectomy devices are often used in conjunction with other treatments for peripheral artery disease (PAD), such as balloon angioplasty or stenting, to improve blood flow, and alleviate symptoms. They are typically performed in a hospital or outpatient setting and are usually done under local anesthesia. Like all medical procedures, atherectomy carries some risks, including bleeding, infection, and damage to the artery. However, with proper patient selection and technique, atherectomy can be a safe and effective treatment option for peripheral artery disease (PAD). 

The surge in demand for atherectomy devices is due to rise in incidence of cardiovascular diseases, such as atherosclerosis, Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD). Atherosclerosis, which is a condition characterized by the buildup of plaque inside the arteries, leading to the narrowing and hardening of the arteries. This can result in reduced blood flow to vital organs such as the heart and brain, which can lead to serious health problems such as heart attacks and strokes. Furthermore, the prevalence of atherosclerosis has increased in recent years due to various factors, including changes in lifestyle and an aging population. In 2021, according to a report by American Heart Association, atherosclerotic lower extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. 

Furthermore, the elderly population is at a higher risk of developing cardiovascular diseases and other related conditions, such as diabetes and hypertension due to the fact that blood vessels lose elasticity with age, becoming stiffer and less able to expand and contract as needed to regulate blood pressure. In addition, some elderly individuals may have a genetic predisposition to cardiovascular disease (CVDs), such as a family history of heart disease or stroke. Moreover, increase in demand for minimally invasive procedures due to reduced pain, shorter hospital stays, and faster recovery times is expected to drive the market growth during the forecast period. 

In addition, the rise in healthcare expenditure in both developed and developing countries drives demand for atherectomy devices, as healthcare providers seek to offer the latest and most effective treatments to their patients. Thus, these were the major factors that contribute to the growth of the atherectomy devices market. However, factors such as high cost of atherectomy treatment, limited availability of skilled healthcare professionals, and risk of complications might restrain the growth of the atherectomy devices market. 

The atherectomy devices market is segmented into type, end user, and region. By type, the market is categorized into directional atherectomy devices, rotational atherectomy devices, orbital atherectomy devices, and others. By end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major key players that operate in the global atherectomy devices market include Medtronic plc, Koninklijke Philips N.V., Boston Scientific Corporation, Cardiovascular Systems, Inc., Becton, Dickinson and Company, AngioDynamics Inc., Rex medical, Nipro Corporation, Invamed medical, and Avinger Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the atherectomy devices market analysis from 2021 to 2031 to identify the prevailing atherectomy devices market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the atherectomy devices market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global atherectomy devices market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

Rotational Atherectomy Devices
Orbital Atherectomy Devices
Others
Directional Atherectomy Devices

By End User

Hospitals
Ambulatory surgery centers
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Medtronic plc
Koninklijke Philips N.V.
Boston Scientific Corporation
Cardiovascular Systems, Inc.
Becton, Dickinson and Company
AngioDynamics Inc.
Rex medical
Nipro Corporation
Invamed medical
Avinger Inc.

Please Note: It will take 7-10 business days to complete the report upon order confirmation.


CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increasing prevalence of peripheral artery disease (PAD)
3.4.1.2. Growth in geriatric population
3.4.1.3. Surge in demand for minimally invasive procedures
3.4.2. Restraints
3.4.2.1. Limited availability of skilled healthcare professionals
3.4.3. Opportunities
3.4.3.1. Technological advancement in Atherectomy devices
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: ATHERECTOMY DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Directional Atherectomy Devices
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Rotational Atherectomy Devices
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Orbital Atherectomy Devices
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Others
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: ATHERECTOMY DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Ambulatory surgery centers
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: ATHERECTOMY DEVICES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. Market size and forecast, by Product
6.2.3. Market size and forecast, by End User
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Key market trends, growth factors and opportunities
6.2.4.1.2. Market size and forecast, by Product
6.2.4.1.3. Market size and forecast, by End User
6.2.4.2. Canada
6.2.4.2.1. Key market trends, growth factors and opportunities
6.2.4.2.2. Market size and forecast, by Product
6.2.4.2.3. Market size and forecast, by End User
6.2.4.3. Mexico
6.2.4.3.1. Key market trends, growth factors and opportunities
6.2.4.3.2. Market size and forecast, by Product
6.2.4.3.3. Market size and forecast, by End User
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. Market size and forecast, by Product
6.3.3. Market size and forecast, by End User
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Key market trends, growth factors and opportunities
6.3.4.1.2. Market size and forecast, by Product
6.3.4.1.3. Market size and forecast, by End User
6.3.4.2. France
6.3.4.2.1. Key market trends, growth factors and opportunities
6.3.4.2.2. Market size and forecast, by Product
6.3.4.2.3. Market size and forecast, by End User
6.3.4.3. UK
6.3.4.3.1. Key market trends, growth factors and opportunities
6.3.4.3.2. Market size and forecast, by Product
6.3.4.3.3. Market size and forecast, by End User
6.3.4.4. Italy
6.3.4.4.1. Key market trends, growth factors and opportunities
6.3.4.4.2. Market size and forecast, by Product
6.3.4.4.3. Market size and forecast, by End User
6.3.4.5. Spain
6.3.4.5.1. Key market trends, growth factors and opportunities
6.3.4.5.2. Market size and forecast, by Product
6.3.4.5.3. Market size and forecast, by End User
6.3.4.6. Rest of Europe
6.3.4.6.1. Key market trends, growth factors and opportunities
6.3.4.6.2. Market size and forecast, by Product
6.3.4.6.3. Market size and forecast, by End User
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. Market size and forecast, by Product
6.4.3. Market size and forecast, by End User
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Key market trends, growth factors and opportunities
6.4.4.1.2. Market size and forecast, by Product
6.4.4.1.3. Market size and forecast, by End User
6.4.4.2. Japan
6.4.4.2.1. Key market trends, growth factors and opportunities
6.4.4.2.2. Market size and forecast, by Product
6.4.4.2.3. Market size and forecast, by End User
6.4.4.3. India
6.4.4.3.1. Key market trends, growth factors and opportunities
6.4.4.3.2. Market size and forecast, by Product
6.4.4.3.3. Market size and forecast, by End User
6.4.4.4. Australia
6.4.4.4.1. Key market trends, growth factors and opportunities
6.4.4.4.2. Market size and forecast, by Product
6.4.4.4.3. Market size and forecast, by End User
6.4.4.5. South Korea
6.4.4.5.1. Key market trends, growth factors and opportunities
6.4.4.5.2. Market size and forecast, by Product
6.4.4.5.3. Market size and forecast, by End User
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Key market trends, growth factors and opportunities
6.4.4.6.2. Market size and forecast, by Product
6.4.4.6.3. Market size and forecast, by End User
6.5. LAMEA
6.5.1. Key trends and opportunities
6.5.2. Market size and forecast, by Product
6.5.3. Market size and forecast, by End User
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Key market trends, growth factors and opportunities
6.5.4.1.2. Market size and forecast, by Product
6.5.4.1.3. Market size and forecast, by End User
6.5.4.2. Saudi Arabia
6.5.4.2.1. Key market trends, growth factors and opportunities
6.5.4.2.2. Market size and forecast, by Product
6.5.4.2.3. Market size and forecast, by End User
6.5.4.3. South Africa
6.5.4.3.1. Key market trends, growth factors and opportunities
6.5.4.3.2. Market size and forecast, by Product
6.5.4.3.3. Market size and forecast, by End User
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Key market trends, growth factors and opportunities
6.5.4.4.2. Market size and forecast, by Product
6.5.4.4.3. Market size and forecast, by End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021
CHAPTER 8: COMPANY PROFILES
8.1. Medtronic plc
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.2. Koninklijke Philips N.V.
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.3. Boston Scientific Corporation
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.4. Cardiovascular Systems, Inc.
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.4.7. Key strategic moves and developments
8.5. Becton, Dickinson and Company
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.5.7. Key strategic moves and developments
8.6. AngioDynamics Inc.
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. Rex medical
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.8. Nipro Corporation
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.8.6. Business performance
8.9. Invamed medical
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.10. Avinger Inc.
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
8.10.6. Business performance
LIST OF TABLES
TABLE 01. GLOBAL ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 02. ATHERECTOMY DEVICES MARKET FOR DIRECTIONAL ATHERECTOMY DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 03. ATHERECTOMY DEVICES MARKET FOR ROTATIONAL ATHERECTOMY DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 04. ATHERECTOMY DEVICES MARKET FOR ORBITAL ATHERECTOMY DEVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 05. ATHERECTOMY DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 06. GLOBAL ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 07. ATHERECTOMY DEVICES MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 08. ATHERECTOMY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 09. ATHERECTOMY DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 10. ATHERECTOMY DEVICES MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 11. NORTH AMERICA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 12. NORTH AMERICA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 13. NORTH AMERICA ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 14. U.S. ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 15. U.S. ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 16. CANADA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 17. CANADA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 18. MEXICO ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 19. MEXICO ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 20. EUROPE ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 21. EUROPE ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 22. EUROPE ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. GERMANY ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 24. GERMANY ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 25. FRANCE ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 26. FRANCE ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 27. UK ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 28. UK ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 29. ITALY ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 30. ITALY ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 31. SPAIN ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 32. SPAIN ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 33. REST OF EUROPE ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 34. REST OF EUROPE ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 35. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 36. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 37. ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 38. CHINA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 39. CHINA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 40. JAPAN ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 41. JAPAN ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 42. INDIA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 43. INDIA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 44. AUSTRALIA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 45. AUSTRALIA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 46. SOUTH KOREA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 47. SOUTH KOREA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 48. REST OF ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 49. REST OF ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 50. LAMEA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 51. LAMEA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 52. LAMEA ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 53. BRAZIL ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 54. BRAZIL ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 55. SAUDI ARABIA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. SAUDI ARABIA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 57. SOUTH AFRICA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 58. SOUTH AFRICA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 59. REST OF LAMEA ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 60. REST OF LAMEA ATHERECTOMY DEVICES MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 61. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 62. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 63. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 64. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 65. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 66. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 67. KONINKLIJKE PHILIPS N.V.: PRODUCT SEGMENTS
TABLE 68. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
TABLE 69. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 70. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 71. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
TABLE 72. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 73. CARDIOVASCULAR SYSTEMS, INC.: KEY EXECUTIVES
TABLE 74. CARDIOVASCULAR SYSTEMS, INC.: COMPANY SNAPSHOT
TABLE 75. CARDIOVASCULAR SYSTEMS, INC.: PRODUCT SEGMENTS
TABLE 76. CARDIOVASCULAR SYSTEMS, INC.: PRODUCT PORTFOLIO
TABLE 77. CARDIOVASCULAR SYSTEMS, INC.: KEY STRATERGIES
TABLE 78. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 79. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 80. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
TABLE 81. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 82. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 83. ANGIODYNAMICS INC.: KEY EXECUTIVES
TABLE 84. ANGIODYNAMICS INC.: COMPANY SNAPSHOT
TABLE 85. ANGIODYNAMICS INC.: PRODUCT SEGMENTS
TABLE 86. ANGIODYNAMICS INC.: PRODUCT PORTFOLIO
TABLE 87. ANGIODYNAMICS INC.: KEY STRATERGIES
TABLE 88. REX MEDICAL: KEY EXECUTIVES
TABLE 89. REX MEDICAL: COMPANY SNAPSHOT
TABLE 90. REX MEDICAL: PRODUCT SEGMENTS
TABLE 91. REX MEDICAL: PRODUCT PORTFOLIO
TABLE 92. NIPRO CORPORATION: KEY EXECUTIVES
TABLE 93. NIPRO CORPORATION: COMPANY SNAPSHOT
TABLE 94. NIPRO CORPORATION: PRODUCT SEGMENTS
TABLE 95. NIPRO CORPORATION: PRODUCT PORTFOLIO
TABLE 96. INVAMED MEDICAL: KEY EXECUTIVES
TABLE 97. INVAMED MEDICAL: COMPANY SNAPSHOT
TABLE 98. INVAMED MEDICAL: PRODUCT SEGMENTS
TABLE 99. INVAMED MEDICAL: PRODUCT PORTFOLIO
TABLE 100. AVINGER INC.: KEY EXECUTIVES
TABLE 101. AVINGER INC.: COMPANY SNAPSHOT
TABLE 102. AVINGER INC.: PRODUCT SEGMENTS
TABLE 103. AVINGER INC.: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. ATHERECTOMY DEVICES MARKET, 2021-2031
FIGURE 02. SEGMENTATION OF ATHERECTOMY DEVICES MARKET, 2021-2031
FIGURE 03. TOP INVESTMENT POCKETS IN ATHERECTOMY DEVICES MARKET (2022-2031)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW BARGAINING POWER OF BUYERS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW THREAT OF NEW ENTRANTS
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALATHERECTOMY DEVICES MARKET
FIGURE 10. ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2021(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR DIRECTIONAL ATHERECTOMY DEVICES, BY COUNTRY 2021 AND 2031(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR ROTATIONAL ATHERECTOMY DEVICES, BY COUNTRY 2021 AND 2031(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR ORBITAL ATHERECTOMY DEVICES, BY COUNTRY 2021 AND 2031(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 15. ATHERECTOMY DEVICES MARKET, BY END USER, 2021(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR HOSPITALS, BY COUNTRY 2021 AND 2031(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ATHERECTOMY DEVICES MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 19. ATHERECTOMY DEVICES MARKET BY REGION, 2021
FIGURE 20. U.S. ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 21. CANADA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 22. MEXICO ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 23. GERMANY ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 24. FRANCE ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 25. UK ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 26. ITALY ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 27. SPAIN ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 28. REST OF EUROPE ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 29. CHINA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 30. JAPAN ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 31. INDIA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 32. AUSTRALIA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 33. SOUTH KOREA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 34. REST OF ASIA-PACIFIC ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 35. BRAZIL ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 36. SAUDI ARABIA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 37. SOUTH AFRICA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 38. REST OF LAMEA ATHERECTOMY DEVICES MARKET, 2021-2031 ($MILLION)
FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 43. COMPETITIVE DASHBOARD
FIGURE 44. COMPETITIVE HEATMAP: ATHERECTOMY DEVICES MARKET
FIGURE 45. TOP PLAYER POSITIONING, 2021
FIGURE 46. MEDTRONIC PLC: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 47. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 48. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 49. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
FIGURE 50. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 51. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 52. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 53. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 54. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 55. CARDIOVASCULAR SYSTEMS, INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 56. CARDIOVASCULAR SYSTEMS, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 57. CARDIOVASCULAR SYSTEMS, INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 58. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 59. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 60. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 61. ANGIODYNAMICS INC.: NET SALES, 2020-2022 ($MILLION)
FIGURE 62. ANGIODYNAMICS INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 63. ANGIODYNAMICS INC.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 64. NIPRO CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 65. NIPRO CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 66. NIPRO CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 67. AVINGER INC.: NET SALES, 2019-2021 ($MILLION)

$5,820
$3,930
$6,540
$9,870

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings